Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Latest Intercepts Confirm Continuity Across Drill Program February 6, 2026 CSE, NSX Team Up to Boost Australia’s Venture Market February 6, 2026 5 Biggest AI ETFs for Investors in 2026 February 6, 2026